2011
DOI: 10.1016/j.jneumeth.2011.04.021
|View full text |Cite
|
Sign up to set email alerts
|

Direct injection into the dorsal root ganglion: Technical, behavioral, and histological observations

Abstract: Direct injection of agents into the dorsal root ganglia (DRGs) offers the opportunity to manipulate sensory neuron function at a segmental level to explore pathophysiology of painful conditions. However, there is no described method that has been validated in detail for such injections in adult rats. We have found that 2 (µl of dye injected through a pulled glass pipette directly into the distal DRG, exposed by a minimal foraminotomy, produces complete filling of the DRG with limited extension into the spinal … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
128
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 88 publications
(131 citation statements)
references
References 33 publications
3
128
0
Order By: Relevance
“…Control animals received midline lumbar skin incision during brief general anesthesia (Isoflurane 2% in O 2 ). Other rats were injected with vectors AAV8-EGFP or AAV8-EGFP-AIP, as described previously (Fischer et al, 2011). Briefly, after exposure through a midline lumbar incision, the intervertebral foramen was enlarged by removal of laminar bone to expose the distal pole of the right 4 th lumbar (L4) and L5 DRGs.…”
Section: Methodsmentioning
confidence: 99%
“…Control animals received midline lumbar skin incision during brief general anesthesia (Isoflurane 2% in O 2 ). Other rats were injected with vectors AAV8-EGFP or AAV8-EGFP-AIP, as described previously (Fischer et al, 2011). Briefly, after exposure through a midline lumbar incision, the intervertebral foramen was enlarged by removal of laminar bone to expose the distal pole of the right 4 th lumbar (L4) and L5 DRGs.…”
Section: Methodsmentioning
confidence: 99%
“…PMCA may be considered a novel site for altering mechanisms leading to the generation of neuropathic pain. The continuing development of molecular therapies and the tolerance of the DRG as a site for intraneuronal injections [45,46] make modulation of PMCA function in sensory neurons a potential future therapy for chronic pain.…”
Section: Discussionmentioning
confidence: 99%
“…When certain capsid tyrosine residues were mutated to phenylalanine (Y733F), transduction efficiency was shown to be greatly increased relative to that seen with vectors with wild-type capsids (12)(13)(14)(15)(16)(17)(18)(19)(20). Most relevant to the current study, AAV is capable of transducing DRG sensory neurons via direct intraganglionic sciatic nerve injection (21,22) and intraperitoneal and intravenous injection (23), as well as via intrathecal injection following lumbar puncture (24)(25)(26)(27). Therefore, we sought to determine if rAAV vectors would be delivered to the same sensory neurons that HSV-1 infects when applied at an epithelial surface that has been treated to expose the underlying sensory nerve termini.…”
mentioning
confidence: 88%